Market Overview:
The global somatic genetic testing market is expected to grow at a CAGR of 10.8% from 2018 to 2030. The market growth is attributed to the increasing demand for personalized medicine, rising prevalence of cancer and other diseases, and technological advancements in somatic genetic testing. Based on type, the global somatic genetic testing market is segmented into products (kits and assays, instruments, and software), services, and applications. The products segment accounted for the largest share of the global market in 2017. This segment is projected to grow at a CAGR of 11% from 2018 to 2030 due to the increasing demand for kits and assays worldwide. Based on services, sequencing services accounted for the largest share of the global market in 2017.
Product Definition:
Somatic genetic testing is a type of genetic test that examines the genes in body cells. It can be used to diagnose or predict a person's risk for developing certain diseases. Somatic genetic tests are often used to screen for cancer, because certain types of cancer can be caused by mutations in the genes that control cell growth.
Product (Kits and Assays, Instruments, and Software):
Product segment includes kits and assays, instruments, and software. Product Kits & Assays held the largest market share in 2016 owing to its repetitive usage in genetic testing procedures. On the other hand, Software is expected to be the fastest growing segment over the forecast period due to its ease of use and cost effectiveness.
Kits & assay are used for performing a wide range of tests such as carrier screening, gene mapping, mutation scanning or prenatal testing (NTP).
Services:
The global services and it's usage in somatic genetic testing market size was valued at USD 6.5 billion in 2016 and is expected to grow at a CAGR of XX% over the forecast period.
Application Insights:
The academic and research institutions segment held the largest revenue share of over 50% in 2017. The growth can be attributed to the rising number of genetic tests that are available only for academic and research institutions. These organizations conduct extensive clinical trials to validate new diagnostic techniques or develop drugs with greater efficiency. As a result, they require large volumes of genomic data for analysis which drives demand for somatic gene testing in this application segment.
Regional Analysis:
North America dominated the global market in 2017. The presence of a large number of players, high adoption rate for advanced technologies, and favorable reimbursement policies are some factors contributing to the growth of this regional market. Moreover, increasing demand for genetic tests from patients is also expected to drive growth during the forecast period.
Asia Pacific is anticipated to witness lucrative CAGR over the forecast period owing to rising healthcare expenditure by governments and private sectors in countries such as China and India. In addition, an increase in awareness about somatic gene testing coupled with growing investments by companies seeking approval for new products or conducting clinical trials will propel revenue generation capacity within this region during the same period.
Growth Factors:
- Increasing demand for personalized medicine
- Growing awareness about the benefits of somatic genetic testing
- Rising prevalence of cancer and other diseases
- Advances in technology and increasing affordability of tests
- Growing number of reference laboratories
Scope Of The Report
Report Attributes
Report Details
Report Title
Somatic Genetic Testing Market Research Report
By Type
Product (Kits and Assays, Instruments, and Software), Services
By Application
Academic and Research Institutions, Hospitals and Diagnostic Laboratories, Pharmaceutical and Biotechnology Companies, Contract Research Organizations, Others
By Companies
Agilent Technologies, Inc., ARUP Laboratories, ASURAGEN INC, Beijing Genomics Institute (BGI) Genomics Co., Ltd, bioMérieux S.A., CENTOGENE N.V, CIRCULOGENE Theranostics, LLC, F. Hoffmann-La Roche Ltd., Guardant Health, Inc., Illumina, Inc., Invivoscribe, Inc., Laboratory Corporation of America Holdings, Mission Bio, NeoGenomics Laboratories, Inc., OmniSeq, Oxford Nanopore Technologies, Ltd., Pacific Biosciences of California, Inc., QIAGEN N.V., Quest Diagnostics Incorporated, Thermo Fisher Scientific Inc.
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
199
Number of Tables & Figures
140
Customization Available
Yes, the report can be customized as per your need.
Global Somatic Genetic Testing Market Report Segments:
The global Somatic Genetic Testing market is segmented on the basis of:
Types
Product (Kits and Assays, Instruments, and Software), Services
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Academic and Research Institutions, Hospitals and Diagnostic Laboratories, Pharmaceutical and Biotechnology Companies, Contract Research Organizations, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Agilent Technologies, Inc.
- ARUP Laboratories
- ASURAGEN INC
- Beijing Genomics Institute (BGI) Genomics Co., Ltd
- bioMérieux S.A.
- CENTOGENE N.V
- CIRCULOGENE Theranostics, LLC
- F. Hoffmann-La Roche Ltd.
- Guardant Health, Inc.
- Illumina, Inc.
- Invivoscribe, Inc.
- Laboratory Corporation of America Holdings
- Mission Bio
- NeoGenomics Laboratories, Inc.
- OmniSeq
- Oxford Nanopore Technologies, Ltd.
- Pacific Biosciences of California, Inc.
- QIAGEN N.V.
- Quest Diagnostics Incorporated
- Thermo Fisher Scientific Inc.
Highlights of The Somatic Genetic Testing Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Product (Kits and Assays, Instruments, and Software)
- Services
- By Application:
- Academic and Research Institutions
- Hospitals and Diagnostic Laboratories
- Pharmaceutical and Biotechnology Companies
- Contract Research Organizations
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Somatic Genetic Testing Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Somatic genetic testing is a type of genetic test that looks at the DNA in cells from a personu2019s body. This type of test can help doctors diagnose certain medical conditions, such as cancer, and can also help identify risks for developing those conditions.
Some of the major players in the somatic genetic testing market are Agilent Technologies, Inc., ARUP Laboratories, ASURAGEN INC, Beijing Genomics Institute (BGI) Genomics Co., Ltd, bioM©rieux S.A., CENTOGENE N.V, CIRCULOGENE Theranostics, LLC, F. Hoffmann-La Roche Ltd., Guardant Health, Inc., Illumina, Inc., Invivoscribe, Inc., Laboratory Corporation of America Holdings, Mission Bio, NeoGenomics Laboratories, Inc., OmniSeq, Oxford Nanopore Technologies, Ltd., Pacific Biosciences of California, Inc., QIAGEN N.V., Quest Diagnostics Incorporated, Thermo Fisher Scientific Inc..
The somatic genetic testing market is expected to grow at a compound annual growth rate of 10.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Somatic Genetic Testing Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Somatic Genetic Testing Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Somatic Genetic Testing Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Somatic Genetic Testing Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Somatic Genetic Testing Market Size & Forecast, 2018-2028
4.5.1 Somatic Genetic Testing Market Size and Y-o-Y Growth
4.5.2 Somatic Genetic Testing Market Absolute $ Opportunity
Chapter 5 Global Somatic Genetic Testing Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Somatic Genetic Testing Market Size Forecast by Type
5.2.1 Product (Kits and Assays
5.2.2 Instruments
5.2.3 and Software)
5.2.4 Services
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Somatic Genetic Testing Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Somatic Genetic Testing Market Size Forecast by Applications
6.2.1 Academic and Research Institutions
6.2.2 Hospitals and Diagnostic Laboratories
6.2.3 Pharmaceutical and Biotechnology Companies
6.2.4 Contract Research Organizations
6.2.5 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Somatic Genetic Testing Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Somatic Genetic Testing Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Somatic Genetic Testing Analysis and Forecast
9.1 Introduction
9.2 North America Somatic Genetic Testing Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Somatic Genetic Testing Market Size Forecast by Type
9.6.1 Product (Kits and Assays
9.6.2 Instruments
9.6.3 and Software)
9.6.4 Services
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Somatic Genetic Testing Market Size Forecast by Applications
9.10.1 Academic and Research Institutions
9.10.2 Hospitals and Diagnostic Laboratories
9.10.3 Pharmaceutical and Biotechnology Companies
9.10.4 Contract Research Organizations
9.10.5 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Somatic Genetic Testing Analysis and Forecast
10.1 Introduction
10.2 Europe Somatic Genetic Testing Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Somatic Genetic Testing Market Size Forecast by Type
10.6.1 Product (Kits and Assays
10.6.2 Instruments
10.6.3 and Software)
10.6.4 Services
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Somatic Genetic Testing Market Size Forecast by Applications
10.10.1 Academic and Research Institutions
10.10.2 Hospitals and Diagnostic Laboratories
10.10.3 Pharmaceutical and Biotechnology Companies
10.10.4 Contract Research Organizations
10.10.5 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Somatic Genetic Testing Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Somatic Genetic Testing Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Somatic Genetic Testing Market Size Forecast by Type
11.6.1 Product (Kits and Assays
11.6.2 Instruments
11.6.3 and Software)
11.6.4 Services
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Somatic Genetic Testing Market Size Forecast by Applications
11.10.1 Academic and Research Institutions
11.10.2 Hospitals and Diagnostic Laboratories
11.10.3 Pharmaceutical and Biotechnology Companies
11.10.4 Contract Research Organizations
11.10.5 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Somatic Genetic Testing Analysis and Forecast
12.1 Introduction
12.2 Latin America Somatic Genetic Testing Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Somatic Genetic Testing Market Size Forecast by Type
12.6.1 Product (Kits and Assays
12.6.2 Instruments
12.6.3 and Software)
12.6.4 Services
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Somatic Genetic Testing Market Size Forecast by Applications
12.10.1 Academic and Research Institutions
12.10.2 Hospitals and Diagnostic Laboratories
12.10.3 Pharmaceutical and Biotechnology Companies
12.10.4 Contract Research Organizations
12.10.5 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Somatic Genetic Testing Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Somatic Genetic Testing Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Somatic Genetic Testing Market Size Forecast by Type
13.6.1 Product (Kits and Assays
13.6.2 Instruments
13.6.3 and Software)
13.6.4 Services
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Somatic Genetic Testing Market Size Forecast by Applications
13.10.1 Academic and Research Institutions
13.10.2 Hospitals and Diagnostic Laboratories
13.10.3 Pharmaceutical and Biotechnology Companies
13.10.4 Contract Research Organizations
13.10.5 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Somatic Genetic Testing Market: Competitive Dashboard
14.2 Global Somatic Genetic Testing Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Agilent Technologies, Inc.
14.3.2 ARUP Laboratories
14.3.3 ASURAGEN INC
14.3.4 Beijing Genomics Institute (BGI) Genomics Co., Ltd
14.3.5 bioMérieux S.A.
14.3.6 CENTOGENE N.V
14.3.7 CIRCULOGENE Theranostics, LLC
14.3.8 F. Hoffmann-La Roche Ltd.
14.3.9 Guardant Health, Inc.
14.3.10 Illumina, Inc.
14.3.11 Invivoscribe, Inc.
14.3.12 Laboratory Corporation of America Holdings
14.3.13 Mission Bio
14.3.14 NeoGenomics Laboratories, Inc.
14.3.15 OmniSeq
14.3.16 Oxford Nanopore Technologies, Ltd.
14.3.17 Pacific Biosciences of California, Inc.
14.3.18 QIAGEN N.V.
14.3.19 Quest Diagnostics Incorporated
14.3.20 Thermo Fisher Scientific Inc.
